DDM News 114.83 05/08/2014 04:41:50 Ultra DOW 30 Proshares (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra DOW 30 Proshares (DDM) 114.83 $DDM

4 Ways to Play the Dow You Might Never Have Thought Of
Dan Caplinger, The Motley Fool - Motley Fool - Sun Feb 16, 8:01AM CST
More ordinary people follow the Dow Jones Industrials than any other market benchmark, and so it's only natural for beginning investors to tie their investment results to the venerable stock market measure. But rather than just buying all 30 of...

Watch for ProShares Ultra Dow30 to Potentially Pullback After Gaining 1.53% Yesterday
Comtex SmarTrend(R) - Thu Dec 26, 4:40PM CST
ProShares Ultra Dow30 (AMEXDM) traded in a range yesterday that spanned from a low of $112.68 to a high of $113.86. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.21 on volume of 218,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of ProShares Ultra Dow30 to Potentially Pullback after Yesterday's 1.53% Rise
Comtex SmarTrend(R) - Thu Dec 26, 4:39PM CST
ProShares Ultra Dow30 (AMEXDM) traded in a range yesterday that spanned from a low of $112.68 to a high of $113.86. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.21 on volume of 218,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.53% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Dec 26, 4:39PM CST
ProShares Ultra Dow30 (AMEXDM) traded in a range yesterday that spanned from a low of $112.68 to a high of $113.86. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.21 on volume of 218,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

AZC, ICE, FXA, DDM Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Jun 06, 5:07AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Augusta Resource Corp (AMEX:AZC), Canlan Ice Sports Corp (NYSE:ICE), CurrencyShares Australian Dollar Trust (NYSE:FXA), ProShares Ultra Dow30 (NYSEDM) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

ProShares Ultra Dow30 Up 38.1% Since SmarTrend Uptrend Call (DDM)
Comtex SmarTrend(R) - Wed Jun 05, 9:38AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 6 months, ProShares Ultra Dow30 has returned 38.05% as of today's recent price of $94.98.

Uptrend Call Working As ProShares Ultra Dow30 Stock Rises 41.7% (DDM)
Comtex SmarTrend(R) - Wed May 29, 9:08AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 6 months, ProShares Ultra Dow30 has returned 41.72% as of today's recent price of $97.50.

42.8% Return Seen to Date on SmarTrend ProShares Ultra Dow30 Call (DDM)
Comtex SmarTrend(R) - Tue May 21, 5:27PM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 6 months, ProShares Ultra Dow30 has returned 42.85% as of today's recent price of $98.28.

Shares of DDM Up 35.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri May 03, 10:59AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 5 months, ProShares Ultra Dow30 has returned 35.28% as of today's recent price of $93.07.

DTH, XKO, VSCP, LUNA, DDM, DLS Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Apr 29, 5:54AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of WisdomTree DEFA Equity Income Fund (NYSETH), Lehman ABS Corp (NYSE:XKO), VirtualScopics Inc (NASDAQ:VSCP), Luna Innovations Inc (NASDAQ:LUNA), ProShares Ultra Dow30 (NYSEDM), WisdomTree International SmallCap Dividend Fund (NYSELS) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

ProShares Ultra Dow30 Shares Up 29.8% Since SmarTrend's Buy Recommendation (DDM)
Comtex SmarTrend(R) - Fri Apr 26, 9:36AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 5 months, ProShares Ultra Dow30 has returned 29.82% as of today's recent price of $89.32.

ProShares Ultra Dow30 Has Returned 32.8% Since SmarTrend Recommendation (DDM)
Comtex SmarTrend(R) - Thu Apr 11, 4:46PM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 5 months, ProShares Ultra Dow30 has returned 32.82% as of today's recent price of $91.38.

Shares of DDM Up 27.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 04, 11:03AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 4 months, ProShares Ultra Dow30 has returned 27.75% as of today's recent price of $87.89.

SSO, MVV, DDM, SWHC, AYR, DVR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Mar 29, 7:33AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Silver Standard Resources Inc (NYSE:SSO), ProShares Ultra MidCap400 (NYSE:MVV), ProShares Ultra Dow30 (NYSEDM), SMITH & WESSON HOLDING CORPORATION (NASDAQ:SWHC), Aircastle Ltd (NYSE:AYR), Cal Dive International Inc (NYSEVR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

ProShares Ultra Dow30 Has Returned 25.6% Since SmarTrend Recommendation (DDM)
Comtex SmarTrend(R) - Thu Mar 21, 9:32AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 4 months, ProShares Ultra Dow30 has returned 25.55% as of today's recent price of $86.38.

Uptrend Call Working As ProShares Ultra Dow30 Stock Rises 22.5% (DDM)
Comtex SmarTrend(R) - Wed Mar 06, 11:10AM CST
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEXDM) on November 23rd, 2012 at $68.80. In approximately 3 months, ProShares Ultra Dow30 has returned 22.51% as of today's recent price of $84.29.

Should You Chase this Rally?
Chad Karnes - ETFG - Thu Jan 03, 11:25PM CST
The markets rallied over 4% on 12/31 and 1/2. Is now the time to chase this rally? We see many reasons to not trust this market's continued advance.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading